THURSDAY, MAY 3, 2018
ACC boosts surgical simulator funding; updates TI data
ACC is spending another $4.8 million to ensure the highly successful surgical simulation training programme NetworkZ
(previously known as MORSim) is rolled out to all DHBs by 2021.
NetworkZ uses surgical mannequins to simulate operating theatre situations designed to help surgical teams develop
better teamwork to improve patient safety.
Initial funding of $4.8 million will see 10 DHBs across the country using NetworkZ by the middle of this year, and Mike
Tully, ACC’s Chief Customer Officer, says rolling it out to all DHBs will put New Zealand at the forefront of healthcare
training.
“There is strong evidence of the benefits of good team training in the healthcare sector, but up to now it is not
something that’s being systematically implemented at a national level. ACC is delighted to be supporting such an
important initiative,” says Mike Tully.
The funding announcement comes as ACC releases the second edition of its treatment injury data publication, covering the
five years up to 30 June 2017. A treatment injury occurs when a patient is inadvertently harmed during the course of
their healthcare treatment.
The publication, released in conjunction with Ministry of Health and the Health Quality and Safety Commission, has been
expanded to include data from New Zealand’s 38 private surgical hospitals. It also covers three more injury areas:
equipment failures, all surgical mesh-related injuries, and treatment omission – where injury was caused by a failure to
provide treatment, or a failure to do so in a timely manner.
Mike Tully says the health sector’s response to last year’s data publication was gratifying.
“We’ve had positive feedback about the useful insights the data is providing clinicians and their managers. The intent
of publishing our data is to allow the health sector to learn from treatment injuries, so we can work together to make
them less likely to occur in the future.
“For example, Hutt Valley DHB noted an increase in infections from the most common medical device used: peripheral
intravenous lines. As a result, they developed a new approach which has led to treatment improvements, and is now
available to all hospitals.”
Dr Peter Robinson, Chief Clinical Advisor, says a greater focus on patient safety across New Zealand has also increased
awareness of treatment injuries, and led to more reporting. However the rates of patient harm here are comparable to
other countries.
“This year’s publication shows there were 9,900 accepted treatment injury claims in 2016/17, which will have a lifetime
cost of $602 million to ACC. Just over 57 percent occurred in public hospitals, which treat more than 1.1 million cases
a year. Private hospitals account for 13 percent, and the rest occur in general practice or other health settings.
“The figures are pretty similar to last year’s data, but that is to be expected. Although several new injury prevention
initiatives have started in the past 12 months, it is still too soon to expect to see the impact of these on injury
rates.”
Mr Tully says ACC is investing $45 million in treatment injury prevention over five years as part of a commitment to
deliver better outcomes for New Zealanders.
“Injury prevention is one of ACC’s core functions. Working in partnership with DHBs, private hospitals, and health
experts, we’ve developed a range of programmes targeting the types of treatment injuries that are high frequency, high
cost, or both.”
ends